About

About

Having the right partner is critical to your success

For over 30 years, IDT Australia has brought our expertise and innovation to projects large and small. Our culture is built on the importance of quality, and we take pride that we have worked with nine of the top ten pharmaceutical companies providing a flexible, comprehensive service from early API and finished dose product development and clinical trial research through to commercial manufacture.

Located in Melbourne and Adelaide we specialise in high containment, high potency manufacture of API and finished dose products (including beta lactams), microbiological and analytical testing, clinical packaging, Phase I and first time in man clinical trials research and pharmacy services. Our facilities are audited by the US FDA and Australia’s TGA and operate to global quality standards.

From the time we receive your project request we work to better understand your needs and strive to uncover solutions that deliver improved costs, more effective outcomes and faster completion rates.

Challenge us with your current project.

Case Study: Accessing up to 45% Cash Rebate

As IDT is a Registered Research Agency with the Australian Industry Research and Development Board, our clients may be eligible for a 45 Cents in the Dollar Cash Rebate or a 40% Tax Shield on eligible R&D activities undertaken by IDT.

With pharmaceutical development projects taking significant time and investment, many IDT clients have used the R&D Tax Incentive scheme to conduct R&D in a very cost efficient manner.  A number of our overseas clients have also taken advantage of the R&D Tax Incentive scheme along with the speedy CTN clinical trial notification scheme available in Australia to fast track their development pathways, whilst claiming up to a 45% cash rebate on their development costs!

Contact us here at IDT to discover more about the Tax Incentive scheme.

about
Global Regulatory Compliance
When it comes to regulatory compliance, IDT has the world covered.

Audit History

US FDA on-site inspection January 2015
TGA Full GMP (Finished Product, API) on-site inspection September 2013
US FDA Full GMP (Finished Product, API) February 2013
TGA Full GMP (Finished Product, API) on-site inspection February 2011
TGA Full GMP (Finished Product, API) on-site inspection June 2009
USFDA Full GMP (Finished Product, API) on-site inspection May 2009
Health Labour and Welfare (Japan) (Non-sterile API) February 2009
TGA (Sterile Product Finished Product) on-site inspection July 2008
TGA Full GMP (Finished Product, API) on-site inspection July 2007
TGA Full GMP (Finished Product) on-site inspection August 2004
TGA Full GMP (Finished Product, API) on-site inspection March 2004
US FDA Full GMP (API) on-site inspection May 2001
US FDA GCP and GLP Audit of IDT CMAX Feb 2000
R&D Tax Credits.

As IDT is a Registered Research Agency with the Australian Industry Research and Development Board, clients may be eligible for a 45 Cents in the Dollar Cash Rebate or a 40% Tax Shield on eligible R&D activities undertaken by IDT under the R&D Tax Incentive scheme.
This scheme is available to overseas companies.

Contact us to find out more about accessing this scheme.